Abstract:Abstract Triple negative breast cancer (TNBC) is characterized by the absence of estrogen, progesterone, and HER2 receptors. It exhibits a higher level of aggressiveness compared to other types of breast cancer, with a greater likelihood of recurrence following standard treatments such as surgery, chemotherapy, and radiation. Despite limited FDA-approved targeted therapies for TNBC, there is an ongoing need for additional molecular targeting agents.Our investigation focused on the role of the receptor tyrosine kinase MerTK and its impact on proliferation and invasion/metastatic potential. Immunohistochemistry analysis revealed that approximately 86% (128/148) expressed varying levels of MerTK in human TNBC samples, whereas approximately 50% (23/47) of TNBC patient-derived xenografts (PDX) expressed MerTK. Additionally, three established TNBC cell lines (BT549, MDAMB231, and MDAMB436) exhibited elevated MerTK expression levels.To further explore the role of MerTK in TNBC, we stably overexpressed MerTK in human TNBC cell lines SUM102 and SUM159, which naturally have low MerTK levels. The results demonstrated that MerTK overexpression led to increases in proliferative potential, robust in vivo tumor growth, heightened migration/invasion potential, and increased lung metastasis. NanoString nCounter analysis of MerTK-overexpressing SUM102 cells (SUM102-MerTK) revealed upregulation of several signaling pathways, including PI3k-Akt, PDGF, and Myc, ultimately driving cell cycle progression, reducing apoptosis, and enhancing cell survival in TNBC.Further investigation using a cytokine array showed increased endoglin production in SUM102-MerTK cells compared to vector control cells. This suggested that MerTK might be creating a conducive environment for increased proliferative and metastatic activity via elevated endoglin expression in TNBC. To ascertain the role of endoglin in increase proliferation and/or invasion potential, we knocked out endoglin in SUM102-MerTK cells. While endoglin knockout SUM102-MerTK cells exhibited similar growth to SUM102-MerTK cells, the number of lung metastases was significantly impacted, indicating that MerTK regulates invasion and metastasis through endoglin in TNBC. Collectively, our data suggests that MerTK regulates a unique proliferative signature allowing for robust tumor growth and increased metastatic potential through endoglin regulation. This suggests that targeting MerTK and endoglin simultaneously may be a viable approach for TNBC patients. Citation Format: Christine Glitchev, Mari Iida, Bridget E. Crossman, Kourtney L. Kostecki, Carlene A. Kranjac, Jillian M. Adams, Peng Liu, Irene Ong, David T. Yang, Irene Kang, Ravi Salgia, Deric L. Wheeler. MerTK drives proliferation and metastasis activity in triple negative breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 6994.

The G protein-coupled receptor TBXA2R activates ERMs to control cell motility and invasion of triple-negative breast cancer cells

ERK3/MAPK6 promotes triple-negative breast cancer progression through collective migration and EMT plasticity

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells

Abstract 6994: MerTK drives proliferation and metastasis activity in triple negative breast cancer

Abstract 5535: Intracellular negative regulators of RTK-Ras-ERK signaling alter breast cancer perception of metastatic niche-derived growth factors

TRPC3-mediated NFATc1 calcium signaling promotes triple negative breast cancer migration through regulating glypican-6 and focal adhesion

Novel roles for ERK5 and cofilin as critical mediators linking ERα-driven transcription, actin reorganization, and invasiveness in breast cancer

Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin

Thy-1 (CD90)-Induced Metastatic Cancer Cell Migration and Invasion Are β3 Integrin-Dependent and Involve a Ca2+/P2X7 Receptor Signaling Axis

Tumor-intrinsic role of ICAM-1 in driving metastatic progression of triple-negative breast cancer through direct interaction with EGFR

TGFβ1-TNFα regulated secretion of neutrophil chemokines is independent of epithelial-mesenchymal transitions in breast tumor cells

Activation of MAPK signaling is associated with migration and invasion of triple-negative breast cancer cells

MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer

ERK1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility

The lysosomal TRPML1 channel regulates triple negative breast cancer development by promoting mTORC1 and purinergic signaling pathways.

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.

Gene expression-phenotype association study reveals the dual role of TNF-α/TNFR1 signaling axis in confined breast cancer cell migration

Estrogen receptor β2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1α

Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation

A Positive Feedback Between Activated Extracellularly Regulated Kinase and Cyclooxygenase/Lipoxygenase Maintains Proliferation and Migration of Breast Cancer Cells

Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGFβ signaling